Post Approval and Surveillance Studies

TII has extensive experience in the design, management and operation of late phase and post market approval studies in both the United State and abroad and strategically designs, operates and manages these studies so that they contribute to a successful product launch and support ongoing commercialization efforts.

These studies enable you to successfully address late stage and post-approval regulatory requirements and generate product experience data from a real-world setting. These studies provide critical data for:

• Gaining competitive market intelligence
• Establishing a leadership position within therapeutic areas of interest
• Obtaining product safety and effectiveness information
• Generating hypotheses to guide additional research
• Accelerating the commercial acceptance of new products
• Cultivating positive relationships with clinicians and patients
• Complying with FDA orders